• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左旋肉碱与癌症恶病质。一、癌症恶病质中的左旋肉碱分布与代谢紊乱。

L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia.

机构信息

Department of Surgical Oncology, Gdynia Oncology Centre, PCK's Maritime Hospital in Gdynia, Gdynia, Poland.

出版信息

Oncol Rep. 2012 Jul;28(1):319-23. doi: 10.3892/or.2012.1804. Epub 2012 May 4.

DOI:10.3892/or.2012.1804
PMID:22562434
Abstract

Cancer cachexia (CC), a progressive loss of body mass, is associated with decreased energy production. Abnormally low levels of L-carnitine (LC) in skeletal muscle means that mitochondrial β-oxidation of long-chain fatty acids (LCFA) does not occur efficiently in patients with CC. We assessed the influence of CC on LC distribution and the effects of parenteral lipid emulsions on plasma LC levels and urinary excretion. Fifty patients with CC were randomly assigned to total parenteral nutrition (TPN) with long-chain triglycerides (LCTs), or LCTs plus medium-chain triglycerides (MCTs) as 50/50. Patients were further separated into those with body-mass index (BMI) ≤ 19 kg/m(2) and BMI >19 kg/m(2). Plasma concentrations of total LC (TC) and free LC (FC) and their urinary excretion were measured, along with skeletal muscle LC levels. On average, plasma FC and TC were higher than reference values in all patients. Patients with BMI ≤ 19 kg/m(2) had lower plasma FC and TC than those with BMI >19 kg/m(2). Skeletal muscle FC in the BMI ≤ 19 kg/m(2) group was lower than reference value, but within the normal range in others. LC and FC urinary excretion was higher than reference values. Plasma LC and its urinary excretion were higher in patients administered pure LCTs relative to those given MCTs/LCTs. A decrease in skeletal muscle LC in cancer patients with CC (BMI ≤ 19 kg/m(2)) correlates with an increase in its plasma levels and increased renal excretion. A diet of MCTs/LCTs reduces LC release from muscle to plasma and urine more effectively than LCTs.

摘要

癌症恶病质(CC)是一种进行性的体重下降,与能量产生减少有关。骨骼肌中左旋肉碱(LC)水平异常降低意味着患有 CC 的患者线粒体β-氧化长链脂肪酸(LCFA)不能有效地进行。我们评估了 CC 对 LC 分布的影响以及肠外脂质乳剂对血浆 LC 水平和尿排泄的影响。50 名 CC 患者被随机分配到长链甘油三酯(LCTs)的全肠外营养(TPN)或 LCTs 加中链甘油三酯(MCTs)的 50/50。患者进一步分为体重指数(BMI)≤19 kg/m2 和 BMI>19 kg/m2。测量了总 LC(TC)和游离 LC(FC)的血浆浓度及其尿排泄量,以及骨骼肌 LC 水平。平均而言,所有患者的血浆 FC 和 TC 均高于参考值。BMI≤19 kg/m2 的患者的血浆 FC 和 TC 低于 BMI>19 kg/m2 的患者。BMI≤19 kg/m2 组的骨骼肌 FC 低于参考值,但在其他人中仍处于正常范围内。LC 和 FC 的尿排泄量高于参考值。与给予 MCTs/LCTs 的患者相比,给予纯 LCTs 的患者的血浆 LC 和 FC 尿排泄量更高。CC(BMI≤19 kg/m2)癌症患者骨骼肌 LC 减少与血浆水平升高和肾脏排泄增加有关。MCTs/LCTs 饮食比 LCTs 更有效地减少肌肉向血浆和尿液中 LC 的释放。

相似文献

1
L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia.左旋肉碱与癌症恶病质。一、癌症恶病质中的左旋肉碱分布与代谢紊乱。
Oncol Rep. 2012 Jul;28(1):319-23. doi: 10.3892/or.2012.1804. Epub 2012 May 4.
2
L-carnitine and cancer cachexia. II. Effects of lipid emulsion used in total parenteral nutrition on parameters of hemostasis and inflammatory state in L-carnitine deficiency in myocytes.左旋肉碱与癌症恶病质。二、全胃肠外营养中使用的脂肪乳剂对肌细胞左旋肉碱缺乏症止血和炎症状态参数的影响。
Oncol Rep. 2012 Jul;28(1):324-9. doi: 10.3892/or.2012.1805. Epub 2012 May 4.
3
[Assay of carnitine in plasma and urine of healthy adults].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002 Apr;24(2):185-7.
4
[Parenterally administered medium-chain triglyceride-induced changes in carnitine metabolism].[胃肠外给予中链甘油三酯引起的肉碱代谢变化]
Infusionstherapie. 1991 Aug;18(4):167-71.
5
Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.总肉碱与酰基肉碱比值:小儿透析患者游离肉碱与脂质参数的关系
Adv Perit Dial. 2006;22:130-5.
6
Serum interleukin-15 levels in cancer patients with cachexia.癌症恶病质患者的血清白细胞介素-15 水平。
Oncol Rep. 2012 Oct;28(4):1443-52. doi: 10.3892/or.2012.1928. Epub 2012 Jul 23.
7
The metabolic effects of two different lipid emulsions used in parenterally fed premature infants--a randomized comparative study.两种不同脂肪乳剂用于肠外营养喂养早产儿的代谢效应:一项随机对照研究。
Early Hum Dev. 2012 Jul;88(7):499-501. doi: 10.1016/j.earlhumdev.2011.12.008. Epub 2012 Jan 13.
8
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.接受卡铂治疗患者的L-肉碱及其短链乙酰-L-肉碱的尿排泄情况。
Cancer Chemother Pharmacol. 2007 Jun;60(1):19-26. doi: 10.1007/s00280-006-0341-3. Epub 2006 Sep 20.
9
Dynamics of L-Carnitine in Plasma and Urine in Patients Undergoing Cisplatin Chemotherapy.顺铂化疗患者血浆和尿液中左旋肉碱的动态变化
Chemotherapy. 2017;62(4):225-230. doi: 10.1159/000464274. Epub 2017 Apr 19.
10
Effects of parenteral structured lipid emulsion on modulating the inflammatory response in rats undergoing a total gastrectomy.胃肠外结构化脂质乳剂对全胃切除大鼠炎症反应的调节作用。
Nutrition. 2009 Jan;25(1):115-21. doi: 10.1016/j.nut.2008.07.015. Epub 2008 Oct 2.

引用本文的文献

1
Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia.急性髓系白血病诊断时的肠道微生物组改变与肌肉无力和厌食有关。
Haematologica. 2024 Oct 1;109(10):3194-3208. doi: 10.3324/haematol.2023.284138.
2
l-carnitine: Nutrition, pathology, and health benefits.左旋肉碱:营养、病理学及健康益处。
Saudi J Biol Sci. 2023 Feb;30(2):103555. doi: 10.1016/j.sjbs.2022.103555. Epub 2022 Dec 30.
3
Nutritional Interventions to Improve Cachexia Outcomes in Cancer-A Systematic Review.营养干预改善癌症恶病质结局的系统评价。
Medicina (Kaunas). 2022 Jul 21;58(7):966. doi: 10.3390/medicina58070966.
4
L-carnitine ameliorates the muscle wasting of cancer cachexia through the AKT/FOXO3a/MaFbx axis.左旋肉碱通过AKT/FOXO3a/MaFbx轴改善癌症恶病质引起的肌肉萎缩。
Nutr Metab (Lond). 2021 Nov 1;18(1):98. doi: 10.1186/s12986-021-00623-7.
5
Pancreatic Cancer Cachexia: The Role of Nutritional Interventions.胰腺癌恶病质:营养干预的作用
Healthcare (Basel). 2019 Jul 9;7(3):89. doi: 10.3390/healthcare7030089.
6
Medium-chain triglycerides/long-chain triglycerides versus long-chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia.中链甘油三酯/长链甘油三酯与长链甘油三酯治疗重度体重减轻的癌症患者。难治性恶病质患者的生存情况。
Prz Gastroenterol. 2016;11(3):181-186. doi: 10.5114/pg.2016.57734. Epub 2016 Feb 8.
7
Cachexia and pancreatic cancer: are there treatment options?恶病质与胰腺癌:有治疗选择吗?
World J Gastroenterol. 2014 Jul 28;20(28):9361-73. doi: 10.3748/wjg.v20.i28.9361.
8
Lower carnitine plasma values from malnutrition cancer patients.
J Gastrointest Cancer. 2013 Sep;44(3):362-5. doi: 10.1007/s12029-013-9497-3.